We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Study Suggests FTY720 May Repair MS Damage By Direct Effect On Brain
Multiple Sclerosis FTY720 (fingolimod), an oral sphingosine-1-phosphate receptor agonist being developed for multiple sclerosis (MS), acts directly on the central nervous system (CNS) to reduce disease severity in addition to peripheral effects on the immune system, according to results from a model of the disease reported at this week's European Committee for Treatment and Research in Multiple Sclerosis congress (Prague, Czech Republic). [click link for full article]
Custom Search
